AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

OLANZAPINE 5 Mg ;

10 registrations across 1 African market— 10 active

Markets with OLANZAPINE 5 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Olazorix 5mg
Film Coated Tablets
🇪🇬EgyptMash for pharmaceutical Industries and cosmetic - mash premiereactive
Ranxapin 5 mg
Tablets
🇪🇬EgyptSun pharma Egypt limitedactive
Olanzapine-Inad Pharma 5 mg
Film Coated Tablets
🇪🇬EgyptInternational advanced pharmaceutical industries (INAD pharma)active
Olanvexa 5mg
orally disintegrating Tablets
🇪🇬EgyptMulticare Egypt for Pharmaceutical Industriesactive
Ranxapin 5 mg
Tablets
🇪🇬EgyptSun pharma Egypt limitedactive
Olanvexa 5mg
orally disintegrating Tablets
🇪🇬EgyptMulticare Egypt for Pharmaceutical Industriesactive
Bioprex 5 mg
Film Coated Tablets
🇪🇬EgyptCLAVITA PHARMAactive
Olazorix 5mg
Film Coated Tablets
🇪🇬EgyptMash for pharmaceutical Industries and cosmetic - mash premiereactive
Olanzapine-Inad Pharma 5 mg
Film Coated Tablets
🇪🇬EgyptInternational advanced pharmaceutical industries (INAD pharma)active
Bioprex 5 mg
Film Coated Tablets
🇪🇬EgyptCLAVITA PHARMAactive

OLANZAPINE 5 Mg ; in Africa — Regulatory Overview

OLANZAPINE 5 Mg ; is registered across 1 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.